We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
7226
CareDx
CDNA
$2.26B
$4K ﹤0.01%
1,000
CRVO icon
7227
CervoMed
CRVO
$23.9M
$4K ﹤0.01%
2
-3
-60% -$6.21K
DIEM icon
7228
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$69.9M
$4K ﹤0.01%
+127
New +$4K
DXLG icon
7229
Destination XL Group
DXLG
$31.2M
$4K ﹤0.01%
1,949
+1,557
+397% +$2.98K
EDOG icon
7230
ALPS Emerging Sector Dividend Dogs ETF
EDOG
$29.5M
$4K ﹤0.01%
178
-39
-18% -$961
FALN icon
7231
iShares Fallen Angels USD Bond ETF
FALN
$1.63B
$4K ﹤0.01%
130
+129
+12,900% +$3.55K
GRVY
7232
GRAVITY
GRVY
$430M
$4K ﹤0.01%
276
-170
-38% -$1.68K
GTIM icon
7233
Good Times Restaurants
GTIM
$14.6M
$4K ﹤0.01%
1,503
-369
-20% -$1.14K
AGIG
7234
Abundia Global Impact Group
AGIG
$42.5M
$4K ﹤0.01%
65
-162
-71% -$11.3K
IMRN
7235
Immuron
IMRN
$8.8M
$4K ﹤0.01%
691
-516
-43% -$3.1K
INUV icon
7236
Inuvo
INUV
$15.1M
$4K ﹤0.01%
431
+215
+100% +$2.17K
IVLU icon
7237
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
$4K ﹤0.01%
151
-4,240
-97% -$105K
JILL icon
7238
J. Jill
JILL
$272M
$4K ﹤0.01%
+92
New +$4.34K
JSMD icon
7239
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.05B
$4K ﹤0.01%
+119
New +$4.12K
LTBR icon
7240
Lightbridge
LTBR
$271M
$4K ﹤0.01%
322
-98
-23% -$1.38K
IMDX
7241
Insight Molecular Diagnostics
IMDX
$150M
$4K ﹤0.01%
28
-65
-70% -$6.81K
OTLK icon
7242
Outlook Therapeutics
OTLK
$183M
$4K ﹤0.01%
15
+3
+25% +$546
SGA icon
7243
Saga Communications
SGA
$57M
$4K ﹤0.01%
+93
New +$3.92K
SLNG icon
7244
Stabilis Solutions
SLNG
$87.8M
$4K ﹤0.01%
330
+50
+18% +$678
TROO icon
7245
TROOPS Inc
TROO
$208M
$4K ﹤0.01%
3,400
+1,515
+80% +$1.66K
TRTX
7246
TPG RE Finance Trust
TRTX
$612M
$4K ﹤0.01%
+208
New +$4.12K
TUSK icon
7247
Mammoth Energy Services
TUSK
$128M
$4K ﹤0.01%
268
-639
-70% -$9.33K
BSIN
7248
Big Sky Industrial
BSIN
$59.6M
$4K ﹤0.01%
553
-840
-60% -$6.23K
VRDN icon
7249
Viridian Therapeutics
VRDN
$2.09B
$4K ﹤0.01%
29
-76
-72% -$12.8K
XBIO icon
7250
Xenetic Biosciences
XBIO
$5.81M
$4K ﹤0.01%
16
+12
+300% +$3.88K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.